8-KShareholder Matters

CME GROUP INC. 8-K Report, Shareholder Vote Results (Jun 10, 2026)

Filed June 10, 2026For Securities:CME

Summary

CME Group Inc. held its reconvened 2026 Annual Meeting of Shareholders on June 9, 2026, to vote on several proposals that were initially adjourned due to a lack of quorum among certain Class B shareholder classes. While a quorum was achieved for the combined Class A and B shares (81.36% present) and for Class B-1 and B-2 shares individually, Class B-3 shares failed to meet the 33.3% quorum requirement, preventing votes on Items 6 and 8c. Key proposals aimed at eliminating the director election rights for Class B-1 and B-2 shareholders (Items 4 and 5) did not pass, meaning these shareholders retain their rights. A proposal to amend the certificate of incorporation (Item 7) technically passed but will not be enacted due to the failure of Items 4, 5, and 6. All Class B-1 and B-2 directors seeking re-election were successful, while the election of a Class B-3 director failed to achieve quorum, resulting in a holdover director.

Key Highlights

  • 1The 2026 Annual Meeting was reconvened on June 9, 2026, after initial adjournment due to quorum issues with Class B shareholders.
  • 2Class B-3 shareholders failed to achieve quorum (28.44% present), preventing votes on specific proposals related to their director election rights.
  • 3Proposals to eliminate the director election rights for Class B-1 and Class B-2 shareholders (Items 4 and 5) were defeated.
  • 4Class A and B shareholders collectively approved an amendment to the certificate of incorporation (Item 7), but its effectiveness is contingent on the failed Items 4, 5, and 6.
  • 5All Class B-1 directors (William H. Hobert, Patrick J. Mulchrone, Robert J. Tierney Jr.) were re-elected.
  • 6The Class B-2 director (Patrick W. Maloney) was re-elected.
  • 7The election of a Class B-3 director failed due to lack of quorum, resulting in a holdover director until the 2027 meeting.

Frequently Asked Questions